Goldman Sachs and Morgan Stanley engaged in joint book-running management of a bond issuance for AstraZeneca.
2 reports, 1 independent
Updated Aug 25
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Goldman Sachs and Morgan Stanley engaged in joint book-running management of a bond issuance for AstraZeneca.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Goldman Sachs International
UK company
Nothing else this week.
-
AstraZeneca
British-Swedish pharmaceutical company
-
Morgan Stanley
U.S. investment bank